Aplications of the molecular biology in the national program of tuberculosis of Chile: A luxury or a true necessity?;Aplicaciones de la biología molecular en el programa nacional de tuberculosis de Chile: ¿Lujo o necesidad?

Revista Chilena de Enfermedades Respiratorias

Volumn 22, Issue 3, 2006, Pages 201-208

  Marcone E, Pablo ^a,b,c  

^a INSTITUTO NACIONAL DEL TÓRAX   (Chile)

^b Servicio de Salud Metropolitano Oriente   (Chile)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33751509008     PISSN: 07175698     EISSN: 07177348     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Informe 2005 del Programa de Control y Eliminación de la Tuberculosis. Ministerio de Salud, Chile.
2. Goessens W H, de Man P, Koeleman J G, Luijendijk A, te Witt R, Endtz H P, et al. Comparison of the COBAS AMPLICOR MTB and BDProbeTec ET assays for detection of Mycobacterium tuberculosis in respiratory specimens. J Clin Microbiol 2005; 43: 2563-6.
3. Thomsen V O, Kok-Jensen A, Buser M, Philippi-Schulz S, Burkardt H J. Monitoring treatment of patients with pulmonary tuberculosis: can PCR be applied? J Clin Microbiol 1999; 37: 3601-7.
4. Ichiyama S, Ito Y, Sugiura F, Iinuma Y, Yamori S, Shimojima M, et al. Diagnostic value of the strand displacement amplification method compared to those of Roche Amplicor PCR and culture for detecting mycobacteria in sputum samples. J Clin Microbiol 1997; 35: 3082-5.
5. Piersimoni C, Scarparo C. Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microbiol 2003; 41: 5355-65.
6. Centers for Disease Control and Prevention Update: Nucleic acid amplification tests for tuberculosis. MMWR Morb Mortal Wkly Rep 2000; 49: 593-4.
7. Horsburgh C R Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004; 350: 2060-7.
8. Streeton J A, Desem N, Jones S L. Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int J Tuberc Lung Dis 1998; 2: 443-50.
9. Shams H, Weis SE, Klucar P, Lalvani A, Moonan P K, Pogoda J M, et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med 2005; 172: 1161-8.
10. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-73.
11. Vareldzis B P, Grosset J, de Kantor I, Crofton J, Laszlo A, Felten M, et al. Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tuber Lung Dis 1994; 75: 1-7.
12. Ovchinnikov Y A, et al. Primary structure of Escherichia coli RNA polymerase nucleotide substitution in the b-subunit gene of rifampicin resistant rpoB255 mutant. Mol Gen Genet 1993; 84: 536-8.
13. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston M J, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647-50.
14. Goyal M, Shaw R J, Banerjee D K, Coker R J, Robertson B D, Young D B. Rapid detection of multidrug-resistant tuberculosis. Eur Respir J 1997; 10: 1120-4.
15. Van Embden J D, Cave M D, Crawford J T, Dale J W, Eisenach K D, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-9.
16. Caminero J A, Pena M J, Campos-Herrero M I, Rodríguez J C, García I, Cabrera P, et al. Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am J Respir Crit Care Med 2001; 164: 1165-70.
17. Burman W J, Reves R R. Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment. Clin Infect Dis 2000; 31: 1390-5.
18. Farga V. Hacia la erradicación de la Tuberculosis. Rev Chil Enf Respir 2006; 22: 55-67.